210 related articles for article (PubMed ID: 25673821)
21. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.
Mo D; Zhao Y; Balajee AS
Cancer Lett; 2018 Jan; 413():1-10. PubMed ID: 29080750
[TBL] [Abstract][Full Text] [Related]
22. PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer.
Ohara AM; Naoi Y; Shimazu K; Kagara N; Shimoda M; Tanei T; Miyake T; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2019 Feb; 173(3):533-543. PubMed ID: 30361874
[TBL] [Abstract][Full Text] [Related]
23. USP37 regulates DNA damage response through stabilizing and deubiquitinating BLM.
Wu C; Chang Y; Chen J; Su Y; Li L; Chen Y; Li Y; Wu J; Huang J; Zhao F; Wang W; Yin H; Wang S; Jin M; Lou Z; Zhu WG; Luo K; Zhang J; Yuan J
Nucleic Acids Res; 2021 Nov; 49(19):11224-11240. PubMed ID: 34606619
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.
Prabhakaran S; Rizk VT; Ma Z; Cheng CH; Berglund AE; Coppola D; Khalil F; Mulé JJ; Soliman HH
Breast Cancer Res; 2017 Jun; 19(1):71. PubMed ID: 28629479
[TBL] [Abstract][Full Text] [Related]
25. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
27. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
[TBL] [Abstract][Full Text] [Related]
28. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
29. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
[TBL] [Abstract][Full Text] [Related]
30. TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.
Lin CH; Chen IC; Huang CS; Hu FC; Kuo WH; Kuo KT; Wang CC; Wu PF; Chang DY; Wang MY; Chang CH; Chen WW; Lu YS; Cheng AL
Sci Rep; 2015 Dec; 5():17879. PubMed ID: 26671300
[TBL] [Abstract][Full Text] [Related]
31. Regulation of gene expression by the BLM helicase correlates with the presence of G-quadruplex DNA motifs.
Nguyen GH; Tang W; Robles AI; Beyer RP; Gray LT; Welsh JA; Schetter AJ; Kumamoto K; Wang XW; Hickson ID; Maizels N; Monnat RJ; Harris CC
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9905-10. PubMed ID: 24958861
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
33. Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase.
Zhang W; Yu X; Bao L; He T; Pan W; Li P; Liu J; Liu X; Yang L; Liu J
Biomed Pharmacother; 2023 Dec; 169():115908. PubMed ID: 37988849
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
[TBL] [Abstract][Full Text] [Related]
35. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
[TBL] [Abstract][Full Text] [Related]
36. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer.
Casey MC; Prakash A; Holian E; McGuire A; Kalinina O; Shalaby A; Curran C; Webber M; Callagy G; Bourke E; Kerin MJ; Brown JA
BMC Cancer; 2019 Jul; 19(1):712. PubMed ID: 31324173
[TBL] [Abstract][Full Text] [Related]
37. Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Kurozumi S; Joseph C; Raafat S; Sonbul S; Kariri Y; Alsaeed S; Pigera M; Alsaleem M; Nolan CC; Johnston SJ; Aleskandarany MA; Ogden A; Fujii T; Shirabe K; Martin SG; Alshankyty I; Mongan NP; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Jul; 176(1):63-73. PubMed ID: 30941650
[TBL] [Abstract][Full Text] [Related]
38. MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis.
Issac MSM; Yousef E; Tahir MR; Gaboury LA
Neoplasia; 2019 Oct; 21(10):1015-1035. PubMed ID: 31476594
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.
Itoh M; Iwamoto T; Matsuoka J; Nogami T; Motoki T; Shien T; Taira N; Niikura N; Hayashi N; Ohtani S; Higaki K; Fujiwara T; Doihara H; Symmans WF; Pusztai L
Breast Cancer Res Treat; 2014 Jan; 143(2):403-9. PubMed ID: 24337596
[TBL] [Abstract][Full Text] [Related]
40. Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
Takahashi H; Oshi M; Asaoka M; Yan L; Endo I; Takabe K
Ann Surg Oncol; 2020 Oct; 27(11):4475-4485. PubMed ID: 32436191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
